Impact of Long-term Hormone Replacement Therapy on In vivo and In vitro Markers of Lipid Oxidation

References

• Ross, R. (1993) "The pathogenesis of atherosclerosis: a perspective for the 1990 s", Nature 362, 801–809.
   PubMed Web of Science ®Google Scholar
• Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C. and Witztum, J.L. (1989) "Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity", N. Engl. J. Med. 320, 915–924.
   PubMed Web of Science ®Google Scholar
• Witztum, J.L. and Steinberg, D. (1991) "Role of oxidized low density lipoprotein in atherogenesis", J. Clin. Investig. 88, 1785–1792.
   PubMed Web of Science ®Google Scholar
• Goldstein, J.L., Ho, Y.K., Basu, S.K. and Brown, US. (1979) "Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition", Proc. Natl Acad. Sci. USA 76, 333–337.
   PubMed Web of Science ®Google Scholar
• Stary, H.C., Chandler, A.B., Glagov, S., Guyton, J.R., Insull, W., Jr, Rosenfeld, M.E., Schaffer, S.A., Schwartz, C.J., Wagner, W.D. and Wissler, R.W. (1994) "A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association", Arterioscler. Thromb. 14, 840–856.
   PubMedGoogle Scholar
• Kannel, W.B. (1987) "Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study", Am. Heart J. 114, 413–419.
   PubMed Web of Science ®Google Scholar
• Castelli, W.P. (1984) "Epidemiology of coronary heart disease: the Framingham study", Am. J. Med. 76, 4–12.
   PubMed Web of Science ®Google Scholar
• Bush, T.L., Barrett-Connor, E., Cowan, L.D., Criqui, M.H., Wallace, R.B., Suchindran, C.M., Tyroler, H.A. and Rifldnd, B.M. (1987) "Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study", Circulation 75, 1102–1109.
   PubMed Web of Science ®Google Scholar
• Lobo, R.A., Notelovitz, M., Bernstein, L., Khan, F.Y., Ross, R.K. and Paul, W.L. (1992) "Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen", Am. J. Obstet. Gynecol. 166, 1182–1188.
   PubMed Web of Science ®Google Scholar
• Farish, E., Rolton, H.A., Barnes, J.F. and Hart, D.M. (1991) "Lipoprotein (a) concentrations in postmenopausal women taking norethisterone", Br. Med. 1303, 694.
   Google Scholar
• Grodstein, F., Manson, J.E., Colditz, G.A., Willett, W.C., Speizer, F.E. and Stampfer, M.J. (2000) "A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease", Ann. Intern. Med. 133, 933–941.
   PubMed Web of Science ®Google Scholar
• Stampfer, M.J. and Colditz, G.A. (1991) "Estrogen replace-ment therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence", Prey. Med. 20, 47–63.
   PubMed Web of Science ®Google Scholar
• McManus, J., McEneny, J., Young, IS. and Thompson, W. (1996) "The effect of various oestrogens and progestogens on the susceptibility of low density lipoproteins to oxidation in vitro", Maturitas 25, 125–131.
   PubMed Web of Science ®Google Scholar
• Maziere, C., Auclair, M., Ronveaux, M.F., Salmon, S., Santus, R. and Maziere, J.C. (1991) "Estrogens inhibit copper and cell-mediated modification of low density lipoprotein", Atherosclerosis 89, 175–182.
   PubMed Web of Science ®Google Scholar
• Rifici, V.A. and Khachadurian, A.K. (1992) "The inhibition of low-density lipoprotein oxidation by 17-beta estradiol", Metabolism 41, 1110–1114.
   PubMed Web of Science ®Google Scholar
• Sack, UN., Rader, D.J. and Cannon, R.O. III. (1994) "Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women", Lancet 343, 269–270.
   PubMed Web of Science ®Google Scholar
• Herrington, D.M., Reboussin, D.M., Brosnihan, KB., Sharp, P.C., Shumaker, S.A., Snyder, T.E., Furberg, CD., Kowalchuk, G.J., Stuckey, T.D., Rogers, W.J., Givens, D.H. and Waters, D. (2000) "Effects of estrogen replacement on the progression of coronary-artery atherosclerosis", N. Engl. J. Med. 343, 522–529.
   PubMed Web of Science ®Google Scholar
• Hulley, S., Grady, D., Bush, T., Furberg, C., Herrington, D., Riggs, B. and Vittinghoff, E. (1998) "Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group", J. Am. Med. Assoc. 280, 605–613.
   PubMed Web of Science ®Google Scholar
• Viscoli, C.M., Brass, L.M., Kernan, W.N., Sarrel, P.M., Suissa, S. and Horwitz, R.I. (2001) "A clinical trial of estrogen-replacement therapy after ischemic stroke", N. Engl. J. Med. 345, 1243–1249.
   PubMed Web of Science ®Google Scholar
• Mc Manus, J., Mc Eneny, J., Thompson, W. and Young, IS. (1997) "The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women", Atherosclerosis 135, 73–81.
   PubMedGoogle Scholar
• Koh, K.K., Mincemoyer, R., Bui, M.N., Csako, G., Pucino, F., Guetta, V, Waclawiw, M. and Cannon, R.O. ifi. (1997) "Effects of hormone-replacement therapy on fibrinolysis in post-menopausal women", N. Engl. J. Med. 336, 683–690.
   PubMed Web of Science ®Google Scholar
• Guetta, V, Panza, J.A., Waclawiw, M.A. and Cannon, R.O. ifi (1995) "Effect of combined 17 beta-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women", Am. J. Cardiol. 75, 1274–1276.
   PubMedGoogle Scholar
• Morrow, J.D., Hill, K.E., Burk, R.F., Nammour, T.M., Badr, K.F. and Roberts, L.J.I. (1990) "A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism", Proc. Natl Acad. Sci. USA 87, 9383–9387.
   PubMed Web of Science ®Google Scholar
• Morrow, J.D., Frei, B., Longmire, A.W., Caziano, J.M., Lynch, S.M., Shyr, Y., Strauss, WE., Oates, J.A. and Roberts, L.J.I. (1995) "Increase in circulating products of lipid permddation (F2-isoprostanes) in smokers: smoking as a cause of oxidative damage", N. Engl. J. Med. 332, 1198–1203.
   PubMed Web of Science ®Google Scholar
• Nguyen, T. and Warnig, R. (1989) "Improved method for separation of total HDL cholesterol and subclasses", Clin. Chem. 35, 1086.
   Web of Science ®Google Scholar
• Friedewald, W.T., Levy, R.I. and Fredrickson, D.S. (1972) "Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin. Chem. 18, 499–502.
   PubMed Web of Science ®Google Scholar
• Leinonen, J., Rantalaiho, V, Solakivi, T., Koivula, T., Wirta, 0., Pasternack, A., Alho, H. and Lehtimäki, T. (1998) "Suscepti-bility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients", Clin. Chim. Acta 28, 163–174.
   Google Scholar
• Grady, D., Herrington, D., Bittner, V, Blumenthal, R., Davidson, M., Illatky, M., Hsia, J., Hulley, S., Herd, A., Khan, S., Newby, L.K., Waters, D., Vittinghoff, E. and Wenger, N. (2002) "Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II)", J. Am. Med. Assoc. 288, 49–57.
   PubMed Web of Science ®Google Scholar
• Knopp, R.H. (1988) "Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime", Am. J. Obstet. Gynecol. 158, 1630–1643.
   PubMed Web of Science ®Google Scholar
• Wakatsuki, A. and Sagara, Y. (1996) "Effects of continuous medroxyprogesterone acetate on lipoprotein metabolism in postmenopausal women receiving estrogen", Maturitas 25, 35–44.
   PubMed Web of Science ®Google Scholar
• Austin, M.A., Hokanson, J.E. and Edwards, K.L. (1998) "Hypertriglyceridemia as a cardiovascular risk factor", Am. J. Cardiol. 81, 7B–12B.
   Google Scholar
• Humphries, K.H. and Gill, S. (2003) "Risks and benefits of hormone replacement therapy: the evidence speaks", CMAJ 168, 1001–1010.
   PubMed Web of Science ®Google Scholar
• Schaefer, E.J., Lamon-Fava, S., Jenner, J.L., McNamara, J.R., Ordovas, J.M., Davis, C.E., Abolafia, J.M., Lippel, K. and Levy, R.I. (1994) "Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial", J. Am. Med. Assoc. 271, 999–1003.
   PubMed Web of Science ®Google Scholar
• Wakatsuki, A., Ikenoue, N. and Sagara, Y. (1998) "Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women", Maturitas 28, 229–234.
   PubMed Web of Science ®Google Scholar
• Mueck, A.O., Seeger, H. and Lippert, T.H. (1998) "Estradiol inhibits LDL oxidation: do the progestins medroxyprogester-one acetate and norethisterone acetate influence this effect?", Clin. Exp. Obstet. Gynecol. 25, 26–28.
   PubMedGoogle Scholar
• Arteaga, E., Rojas, A., Villaseca, P., Bianchi, M., Arteaga, A. and Duran, D. (1998) "In vitro effect of estradiol, proge-sterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopau-sal women", Menopause 5, 16–23.
   PubMed Web of Science ®Google Scholar
• Zhu, X., Bonet, B. and Knopp, R.H. (2000) "Estradiol 17 beta inhibition of LDL oxidation and endothelial cell cytotoxicity is opposed by progestins to different degrees", Atherosclerosis 148, 31–41.
   PubMed Web of Science ®Google Scholar
• Chahboun, S., Tallineau, C., Pontcharraud, R., Guettier, A. and Piriou, A. (1990) "Polyunsaturated fatty acid profiles and alpha-tocopherol levels in plasma and whole blood incubated with copper. Evidence of inhibition of lipopermddation in plasma by hemolysate", Biochim. Biophys. Acta 1042, 324–329.
   PubMedGoogle Scholar
• Wen, Y, Doyle, M.C., Harrison, R.F. and Feely, J. (1997) "The effect of hormone replacement therapy on vitamin E status in postmenopausal women", Maturitas 26, 121–124.
   PubMed Web of Science ®Google Scholar
• Kuo, S.M., Stout, A., Wactawski-Wende, J. and Leppert, P.C. (2002) "Ascorbic acid status in postmenopausal women with hormone replacement therapy", Maturitas 41, 45–50.
   PubMedGoogle Scholar
• Wakatsuki, A., Ikenoue, N. and Sagara, Y. (1997) "Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women", Obstet. Gynecol. 90, 22–25.
   PubMedGoogle Scholar
• Mackness, MI. and Durrington, EN. (1995) "HDL, its enzymes and its potential to influence lipid peroxidation", Atherosclerosis 115, 243–253.
   PubMed Web of Science ®Google Scholar
• Koivu, T.A., Dastidar, P., Jokela, H., Nikkari, ST., Jaakkola, 0., Koivula, T., Punnonen, R. and Lehtimaki, T. (2001) "The relation of oxidized LDL autoantibodies and long-term hormone replacement therapy to ultrasono-graphically assessed atherosclerotic plaque quantity and severity in postmenopausal women", Atherosclerosis 157, 471–479.
   PubMedGoogle Scholar
• Morrow, J.D., Awad, J.A., Boss, H.J., Blair, I.A. and Roberts, L.J.I. (1992) "Non-cyclooxygenase-derived prosta-noids (F2-isoprostanes) are formed in situ on phospholipids", Proc. Natl Acad. Sci. USA 89, 10721–10725.
   PubMed Web of Science ®Google Scholar
• Catella, E, Reilly, M.P., Delanty, N., Lawson, J.A., Moran, N., Meagher, E. and FitzGerald, G.A. (1995) "Physiological formation of 8-epi-PGF2e, in vivo is not affected by cydooxygenase inhibition", Adv. Prostaglandin Tromboxane Len/cot. Res. 23, 233–236.
   PubMedGoogle Scholar
• Turpeinen, A.M., Basu, S. and Mutanen, M. (1998) "A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans", Prostaglandins Leukot. Essent. Fatty Acids 59, 229–233.
   PubMedGoogle Scholar
• Basu, S., Smedman, A. and Vessby, B. (2000) "Conjugated linoleic acid induces lipid peroxidation in humans", FEBS Lett. 468, 33–36.
   PubMed Web of Science ®Google Scholar
• Ke, R.W., Todd Pace, D. and Ahokas, R.A. (2003) "Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women", Fertil. Steril. 79, 1118–1122.
   PubMed Web of Science ®Google Scholar